Occurrence of Multiple, Extensive and Pan Drug-Resistant Pseudomonas aeruginosa and Carbapenemase Production from Presumptive Isolates Stored in a Biobank at Ethiopian Public Health Institute-Reference-Cited by-同舟云学术

Occurrence of Multiple, Extensive and Pan Drug-Resistant Pseudomonas aeruginosa and Carbapenemase Production from Presumptive Isolates Stored in a Biobank at Ethiopian Public Health Institute

Published:2021-09 Issue: Volume:Volume 14 Page:3609-3618
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Addis Tesfa,Araya Shambel^ORCID,Desta Kassu^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference31 articles.

1. Fujitani S, Moffett KS, Yu V. Pseudomonas aeruginosa. Antimicrobe: infectious Disease & Antimicrobial Agents; 2017. Available from: http://www.antimicrobe.org/new/b112.asp. Accessed August 19, 2021

2. Molecular characterization of clinical and environmental Pseudomonas aeruginosa isolated in a burn center

3. Valid publication of names of prokaryotes according to the rules of nomenclature: past history and current practice

4. Introduction: Pseudomonas aeruginosa

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of meropenem-resistant Pseudomonas Aeruginosa in Ethiopia: a systematic review and meta‑analysis;Antimicrobial Resistance & Infection Control;2024-04-10

2. Study of the Antibacterial Activity of Superhydrophilic and Superhydrophobic Copper Substrates against Multi-Drug-Resistant Hospital-Acquired Pseudomonas aeruginosa Isolates;International Journal of Molecular Sciences;2024-01-08

3. A South African Perspective on the Microbiological and Chemical Quality of Meat: Plausible Public Health Implications;Microorganisms;2023-10-03

4. Epidemiology and Multidrug Resistance of Pseudomonas aeruginosa and Acinetobacter baumanni Isolated from Clinical Samples in Ethiopia;Infection and Drug Resistance;2023-05

5. Towards Translation of PqsR Inverse Agonists: From In Vitro Efficacy Optimization to In Vivo Proof‐of‐Principle;Advanced Science;2023-01-03